The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to phase out animal testing for monoclonal antibodies (mAbs) in the preclinical stage, ...
The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results